Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
2020 · Blood · 78 citations
https://doi.org/10.1182/blood.2020006923
N
Niloufer Khan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
2.8K
Citations
15
h-index
18
i10-index
Niloufer Khan is an academic researcher from City Of Hope National Medical Center. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Cutaneous lymphoproliferative disorders research & T-cell and Retrovirus Studies. The author has an h-index of 15, co-authored 69 publications.
ORCID: 0000-0002-8631-5710Papers by this author
worksSingle agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma treatment (COMPLETE) registry
2019 · American Journal of Hematology · 41 citations
https://doi.org/10.1002/ajh.25463
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma
2022 · Blood Cancer Journal · 5 citations
https://doi.org/10.1038/s41408-022-00620-w
Interim Efficacy Analysis of a Phase II Study Demonstrates Promising Activity of the Combination of Pembrolizumab (PEM) and Entinostat (ENT) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (HL)
2021 · Blood · 3 citations
https://doi.org/10.1182/blood-2021-154226
Efdamrofusp alfa: an insight into the novel drug and its use in age-related macular degeneration
2025 · International Journal of Retina and Vitreous · 0 citations
https://doi.org/10.1186/s40942-025-00685-2
Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study
2025 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-7607922/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat